Peanut allergy treatment study
Part of Immune system & allergy clinical trials.
This trial tests an investigational medication called LP-003 to see if it can reduce allergic reactions to peanuts. It may help people who are allergic to peanuts be able to tolerate small amounts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 55 years old.
- You have a doctor-confirmed allergy to peanuts or peanut-containing foods.
- You have a positive skin prick test for peanut allergy and a blood test showing peanut-specific antibodies.
- You can eat up to 100 mg of peanut protein (about 1/30 of a peanut) and have an allergic reaction, as confirmed by a supervised food challenge.
- You are willing to avoid peanuts and peanut-containing foods during the study and use effective birth control if applicable.
- You have not had a life-threatening allergic reaction requiring intubation or caused by peanuts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This early-phase study tests a new investigational medication (MY006) to see if it is safe and how the body processes it. It is given to both healthy volunteers and people with peanut allergy. The goal is to gather safety information before larger trials.
This study is testing a new blood test to help diagnose peanut allergy. If you are already having blood drawn, they will take two extra small tubes of blood to see how well the test works.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
This trial tests a new immunotherapy called UKK-0018 to treat peanut allergies in adults. The goal is to help your body become less sensitive to peanuts over time.
Hear when a new Peanut Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.